Carmel woman hopeful after participating in clinical trial for new Alzheimer's drug

  • 📰 wrtv
  • ⏱ Reading Time:
  • 33 sec. here
  • 4 min. at publisher
  • 📊 Quality Score:
  • News: 23%
  • Publisher: 51%

FDA Approved News

Kisunla,Alzheimers

'It gives people like me so much hope.' The FDA approved an Eli Lilly drug for people with early signs of Alzheimer’s.

INDIANAPOLIS — A newly approved drug is a sign of hope for thousands of Hoosiers facing Alzheimer’s disease and the loved ones who care for them.

"I'm just, I feel overwhelmed. I've been very emotional today. Because now there's so much hope for other people with the same diagnosis that I have," Patricia Bishara said."When I heard the diagnosis, my first thoughts were, I won't remember my children and my grandchildren's names in five years," Bishara said.

"The new drug is called Kisunla. And it can slow the progression of Alzheimer's disease again when it's provided to those living in the early stages of the disease," Natalie Sutton, Chapter Executive of Alzheimer’s Association Greater Indiana Chapter said.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 598. in LAW

Law Law Latest News, Law Law Headlines